A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants
Clinical trial NCT02555124 · COMPLETED
Trial details
- NCT number
- NCT02555124
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-12
- Primary completion
- 2015-10-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.